This page is a guide to XBI, the SPDR S&P; Biotech ETF offered by SPDR.
Last Price
$45.60
-0.98%
How is XBI Categorized as an ETF?
All ETFs
1,754 funds
Asset Class
985 ETFs
Category
273 ETFs
Sub-Category
9 ETFs
How Does XBI Compare to Its Category Competitors?
The percentile shown for each metric indicates how XBI compares to other ETFs in the Sector Stock category. Wondering how percentiles work? Short version: 99th percentile is good, 0th is bad.
Assets and Yield
Assets (Millions)
$1,499.80
87th Percentile
Dividend Yield
0.84%
22nd Percentile
Returns
YTD Return
-28.06%
1st Percentile
5 Year Return
20.16%
98th Percentile
Portfolio
Number of Holdings
104
79th Percentile
% Assets in Top 10
19.36%
89th Percentile
Expenses
Expense Ratio
0.35%
85th Percentile
Fund Turnover
78.00%
10th Percentile
XBI vs. Other Sector Stock ETFs: All the Data You Could Possibly Want
The table below shows additional financial metrics for XBI as well as all other ETFs in the Sector Stock category. To compare XBI to its broader asset class peer group, visit the Stock page. To compare XBI to its narrower sub-category peer group, visit the Biotech ETFs page.
Click on the tabs (Expenses, Returns, Yield, Holdings) to view additional data for XBI and all ETFs in the Sector Stock category.
| Ticker | ETF | Assets ($M) | Inception Date | Issuer |
|---|---|---|---|---|
| Category Average | N/A | $821.16 | N/A | N/A |
| Ticker | ETF | Expense Ratio | Fund Turnover |
|---|---|---|---|
| Category Average | N/A | 0.62% | 33.14% |
| Ticker | ETF | YTD | 1-Month | 3-Month | 6-Month | 1-Year | 3-Year | 5-Year | 10-Year |
|---|---|---|---|---|---|---|---|---|---|
| Category Average | N/A | -7.91% | -7.58% | -11.49% | -15.36% | -13.96% | 1.53% | 2.85% | 5.10% |
| Ticker | ETF | 12 Month Yield | 30 Day SEC Yield | Dividend Frequency | Capital Gains Frequency |
|---|---|---|---|---|---|
| Category Average | N/A | 3.03% | 2.29% | N/A | N/A |
| Ticker | ETF | Number of Holdings | Number of Long Holdings | Number of Short Holdings | % Assets in Top 10 |
|---|---|---|---|---|---|
| Category Average | N/A | 84 | 84 | 2 | 47.79% |
XBI Portfolio
| Asset Class | Weight |
|---|---|
| US Stock Weighting | 99.79% |
| Cash Weighting | 0.15% |
| Other Weighting | 0.06% |
| Top Holdings | Weight |
|---|---|
| Baxalta Inc | 2.16% |
| AbbVie Inc | 2.03% |
| Amgen Inc | 1.97% |
| Intrexon Corp | 1.96% |
| Ligand Pharmaceuticals Inc | 1.94% |
| Cepheid | 1.94% |
| Biogen Inc | 1.93% |
| Celgene Corp | 1.86% |
| Myriad Genetics Inc | 1.85% |
| AMAG Pharmaceuticals Inc | 1.71% |
Other XBI Metrics
Management
- Issuer
- SPDR
- Inception Date
- 01/31/2006
- Management Style
- Passive
- Benchmark
- S&P; Biotechnology Select Industry TR USD
Dividend Data
- Dividend Frequency
- Quarterly
- Capital Gains Frequency
- Annually
- Annual Dividend
- $0.59
Pricing Data
- Day Range
- $44.37 / $46.18
- Bid/Ask
- $45.49 / $45.59
- 52 Week Low/High
- $44.16 / $91.11
Other Information
- Leveraged Fund
- No
